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socio-cultural determinants in low and high
income countries
Sara Gari1,2, Camilo Doig-Acuña3, Tino Smail4, Jacob RS Malungo5, Adriane Martin-Hilber1,2 and Sonja Merten1,2*
Abstract
Background: The role of socio-cultural factors in influencing access to HIV/AIDS treatment, care and support is
increasingly recognized by researchers, international donors and policy makers. Although many of them have been
identified through qualitative studies, the evidence gathered by quantitative studies has not been systematically
analysed. To fill this knowledge gap, we did a systematic review of quantitative studies comparing surveys done in
high and low income countries to assess the extent to which socio-cultural determinants of access, identified
through qualitative studies, have been addressed in epidemiological survey studies.
Methods: Ten electronic databases were searched (Cinahl, EMBASE, ISI Web of Science, IBSS, JSTOR, MedLine,
Psyinfo, Psyindex and Cochrane). Two independent reviewers selected eligible publications based on the
inclusion/exclusion criteria. Meta-analysis was used to synthesize data comparing studies between low and high
income countries.
Results: Thirty-four studies were included in the final review, 21 (62%) done in high income countries and 13 (38%)
in low income countries. In low income settings, epidemiological research on access to HIV/AIDS services focused
on socio-economic and health system factors while in high income countries the focus was on medical and
psychosocial factors. These differences depict the perceived different barriers in the two regions. Common factors
between the two regions were also found to affect HIV testing, including stigma, high risk sexual behaviours such
as multiple sexual partners and not using condoms, and alcohol abuse. On the other hand, having experienced
previous illness or other health conditions and good family communication was associated with adherence to ART
uptake. Due to insufficient consistent data, a meta-analysis was only possible on adherence to treatment.
Conclusions: This review offers evidence of the current challenges for interdisciplinary work in epidemiology and
public health. Quantitative studies did not systematically address in their surveys important factors identified in
qualitative studies as playing a critical role on the access to HIV/AIDS services. The evidences suggest that the
problem lies in the exclusion of the qualitative information during the questionnaire design. With the changing
face of the epidemic, we need a new and improved research strategy that integrates the results of qualitative
studies into quantitative surveys.
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Background
Socio-cultural diversity needs to be considered during
the design of HIV/AIDS policies and programmes. Social
attitudes and prejudices towards people living with HIV/
AIDS, sexual taboos and gender inequality are some of the
most important challenges for prevention and treatment
of HIV/AIDS [1-6]. Despite an improved performance of
health and community services, people living with HIV/
AIDS continue to face persistent, deeply rooted, social
and cultural barriers.
International donors, public health experts, programme
planners and policy makers need to begin to recognize the
need to take into account this socio-cultural diversity in
program planning. Hence it is essential to gather the
scientific evidence generated so far on this topic. Much
of this evidence has been generated from qualitative
studies. The most important and frequently reported
socio-cultural barriers in both low income and high
income countries include fear of disclosure, anticipation
of stigma, limited social support, interpersonal violence and
alcohol abuse [2-7]. To better understand the distribution,
frequency, and potential impact that these factors may have
on the population, quantitative epidemiological surveys
should ideally incorporate similar questions. It is currently
unclear to what extent socio-cultural determinants of
access, identified by qualitative studies, are addressed
in survey studies. To our knowledge there is no sys-
tematic review of epidemiological literature available
to clarify this question. Therefore, this article seeks to
answer three questions: What socio-cultural factors
have been measured in epidemiologic studies to assess
access to HIV/AIDS services? What are the differences
between factors measured in low and high income
countries? And what are the associations and effect
sizes of these factors?
Methods
A systematic search of quantitative studies addressing
factors that influence access to HIV testing, uptake of anti-
retroviral therapy (ART) and adherence to antiretroviral
(ARV) regimens was performed. In order to determine the
differences between the factors studied in low and high
income and test whether these differences were consistent
with the findings of qualitative studies for each context we
scrutinized studies from low and low-middle income coun-
tries and from upper-middle and high-income countries as
defined by the World Bank Classification [8].
To facilitate the comparative analysis and the description
of the results the countries belonging to these four income
groups were reclassified into two broader categories: low
and high income countries. The category low-income
countries included low income countries and low-middle
income countries and the high-income category included
upper-middle and high-income countries.
Search strategy
The search was restricted to studies with sample population
over 18 years old and in English, French, German, Spanish,
Portuguese and Italian. No other limitations were applied.
The systematic search lasted one day with date 07th
October 2011. The search terms were: ‘HIV OR AIDS’,
‘voluntary counselling and testing’ ‘HAART OR antiretro-
viral*’, ‘compliance OR adherence’, ‘factors OR determinant*
OR barriers’ and ‘motivat* OR facilitat*’. The search
included Cinahl, EMBASE, CSA databases, IBSS, ISI Web
of Science, JSTOR, MedLine, Psyinfo and Psyindex and
the Cochrane Database of Systematic Reviews. Conference
abstracts from the International AIDS Society conferences
web site were also searched. We complemented the search
by reviewing the bibliographies of key papers. The detailed
search strategy is available upon request.
Inclusion and exclusion criteria
To be eligible, articles needed to: report an original research
study; measure one of these three outcomes: HIV testing,
initiation of ART and adherence to antiretroviral therapy;
study associations (of one of the three outcomes) with
socio-cultural factors; target adult participants over 18
years old; apply a survey methodology for data collec-
tion; estimate risk effects as an outcome; and control
for confounding in the analysis. Studies that reported
socio-demographic or socio-economic factors but not
any of the other categories of socio-cultural variables
were excluded.
Study selection and quality appraisal
The study selection followed a four-step process: title
review; abstract review; full text review and quality ap-
praisal. First, two of the authors independently reviewed
all identified study titles. Duplicates and titles that did
not meet the inclusion criteria were removed. The same
authors then independently assessed the abstracts, and
then the full papers of those abstracts that met the
eligibility criteria. Finally, a quality appraisal was done on
all full texts using consolidated criteria of the STROBE
guidelines [9]. STROBE is a checklist of 22 items that must
be addressed in the report of observational studies. This
list is not really a tool to assess the quality of observational
research but provides valuable guidance on the quality of
reporting the studies.
In addition, a modified version of the Newcastle–Ottawa
Scale (NOS) for observational studies (e.g. cross-sectional
and cohort studies) was used to assess the methodological
quality [10]. NOS is a tool to assess the quality of non
randomized studies to be used in a systematic review. Each
study is judged with a 'star system' on three points: the se-
lection of the study groups, the comparability of the groups,
and the ascertainment of the exposure or outcome. In our
review, only studies in which five of nine items on the NOS
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were deemed satisfactory and in which appropriate statis-
tical analysis (e.g. multivariate controlling for confounders)
was conducted were considered to be of high methodo-
logical quality (maximum score of 9). At each stage of the
quality assessment the reviewers discussed together until a
consensus on which studies to include was reached. Finally,
the reviewers manually searched the reference lists of
the included articles for further key studies that could
potentially be included in the analysis.
Data extraction and classification
The following data was extracted and summarized in
evidence tables: citation; year of publication; country; study
design and sampling; characteristics of the study popula-
tion; community versus facility based; sample; outcomes
(HIV testing, uptake of ART, adherence and dropout); and
factors that facilitated and/or hindered access to HIV care
such as: socio-demographic; socioeconomic; medical; health
system; knowledge and beliefs; risky health behaviours;
psychosocial; stigma and discrimination; family and
interpersonal violence; communication about HIV/AIDS;
community prevalence. An overview of data extraction is
provided in Tables 1 and 2.
The data was extracted and reviewed in duplicate from
identified studies. Common indicators were grouped into
bigger categories (factors) in duplicate by independent re-
viewers. Disagreements in the categorization of the factors
were discussed until consensus was reached. Countries of
the study were classified as high or low income countries
as defined by the World Bank [8]. Odds ratio (OR) or
similar estimates (e.g. relative risk, hazard ratio) and
their respective confidence intervals for every unique
risk estimate involving a specific indicator and the uptake
of testing, initiating ART and adhering to ART were
extracted when available.
Statistical analysis
Descriptive statistics were used to examine patterns across
countries with respect to: proportion (%) of factors studied
in relation to access to HIV/AIDS care, estimated effect
sizes (adjusted odd ratios) identified (protective vs risk)
for each factor and the precision around the estimates
(95% confidence intervals). Additionally meta-analysis
was done for nine specific socio-cultural factors identified
by the studies as statistically significantly associated with
adherence to antiretroviral therapy. Despite the expected
heterogeneity within the review (great variability of the
measures used to study socio-cultural factors) we assessed
the comparability of the results from individual studies
using the I2 statistic for quantifying inconsistency. An
overall I2 test-value greater than 60% was considered as in-
dicative of a high level of heterogeneity for which statistical
pooling was not appropriate. Further analyses included
sensitivity analysis performed by removing the studies that
contributed to the heterogeneity in the meta-analysis and
subgroup analyses to compare high-income countries with
low-income countries. A p-value of less than 0.05 was
considered statistically significant. Analyses were performed
in STATA 12.1.
Results
Study selection
The primary search strategy identified 1,671 potentially
relevant citations. After searching for duplicates 715 cita-
tions were discarded. Initial title and abstract screening
excluded 815 manuscripts based on the inclusion - exclu-
sion criteria. The remaining 141 were then retrieved for full
text review. A further 86 manuscripts were excluded as not
meeting the inclusion criteria. The remaining 55 manu-
scripts were quality appraised and 21 were excluded as they
did not deal with confounding in their analysis. Thirty-
four articles were included in our analysis. Figure 1
displays the flow chart of the selection process.
Study characteristics
All 34 included studies employed a quantitative method-
ology (surveys) and used structured questionnaires to deter-
mine potential factors. 13 studies (38%) were conducted in
low income countries [11-23] and 21 (62%) in high income
countries [24-44]. The studies conducted in low income
countries included one from Cameroon [11], Zambia [12],
Nigeria [13], Peru [14], Ethiopia [15], Kenya [16], Ghana
[17], Uganda [18],, Vietnam [19], India [20], Tanzania [21],
Zimbabwe [22] and Malawi [23]. From high income coun-
tries, nine studies were from USA [26,28,30,33,34,39-42],
four from South Africa [31,35,36,44], three from Brazil
[27,37,38] and one each from Italy [24], Denmark [25],
Australia [29], Thailand [32] and China [43].
A total of 29 studies (85%) were clinic based
[11-16,18-21,24-35,37-40,42] and five (15%) were situated
at community level [17,22,23,36,44]. Twenty-four studies
(70%) focused on adherence to ART [11-15,20,21,
24-30,32-39,41-43], five studies (15%) focused on uptake of
voluntary and counselling testing (VCT) [17,22,23,36,44],
four (11%) on ART initiation [16,18,19,26] and one (3%) on
attrition [31]. Table 1 displays the characteristics of the
studies.
Factors measured by quantitative surveys to study access
to HIV/AIDS-care in high- and low-income countries
12 factors were identified as measured by the studies
to assess access to HIV care: (i) socio-demographic, (ii)
socioeconomic, (iii) medical, (iv) health system, (v)
knowledge and beliefs, (vi) risky health behaviours, (vii)
psychosocial, (viii) stigma and discrimination, (ix) family
(x) interpersonal violence, (xi) communication about
HIV/AIDS and (xii) community prevalence. Table 2
shows an outline of the factors identified per study.
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Comparative analysis showed important divergences
across countries. Surveys in low income countries tended
to focus on the study of socio-demographic, socio-
economic and health system factors in relation to access
to HIV/AIDS services [24,25,27,29,31,32,34-40,42-44] while
in high income countries the emphasis was on medical and
psychosocial conditions [25-27,29,32,33,35,38,40-42].
Figure 2 graphically displays the distribution of factors
by country. Socio-demographic, economic, clinical and
sexual behavioural factors were considerably measured
in all surveys conducted in low and high income countries
while interpersonal relationships, communication and
interpersonal violence factors remained highly understudied
in both low and high economic countries. Table 3 displays
the ranking of factors by the proportion of studies where
they were included.
Reported risk factors significantly associated with access
to HIV/AIDS services across countries
Non-uptake of HIV testing in high income countries was
associated with socio-demographic constructs such as be-
ing black [44], being between 25 to 34 years old, and living
in a community with high HIV testing refusal rates [23].
Other barriers included high risk sexual behaviours [36]
such as multiple sexual partners and not using condoms
and enacted stigma [39]. In low income countries, the
Table 1 Characteristics of the studies
Source Year Country Design Population Setting N Outcome
Aloisis 2002 Italy Longitudinal HIV + adults Clinic 366 Adherence
Bardford 2005 Denmark Cross sectional HIV + adults Clinic 887 Adherence
Boyer 2011 Cameroon Cross sectional HIV + adults Clinic 2,381 Adherence
Carlucci 2008 Zambia Cross sectional HIV + adults clinic 424 Adherence
Charurat 2010 Nigeria Longitudinal HIV + adults Clinic 4,529 Adherence
Cunningham 1999 USA Longitudinal HIV + adults Clinic 2,864 Initiation ART
de Castilho 2006 Brazil Longitudinal HIV + adults Clinic 498 Adherence
Franke 2011 Peru Longitudinal HIV + adults Clinic 132 Adherence
Gebo 2003 USA Cross sectional HIV + adults Clinic 196 Adherence
Giday 2010 Ethiopia Cross sectional HIV + adults Clinic 510 Adherence
Grierson 2011 Australia Cross sectional HIV + adults Clinic 1,106 Adherence
Holmes 2007 USA Longitudinal HIV + adults Clinic 116 Adherence
Karcher 2007 Kenya Longitudinal HIV + adults Clinic 159 Initiation ART
Koku 2011 Ghana Cross sectional Female 15-49 Community 3,766 HIV testing
Kranzer 2010 South Africa Longitudinal HIV + adults Clinic 1,154 Defaulting
Kranzer_b 2008 Malawi Cross sectional People 18-59 Community 2,047 HIV testing
Li 2010 Thailand Cross sectional HIV + adults Clinic 386 Adherence
MacPhail 2009 South Africa Cross sectional People 15-24 Community 7,655 HIV testing
Martinez 2008 Uganda Cross sectional HIV + adults Clinic 421 Initiation ART
Mugavero 2006 USA Cross sectional HIV + adults Clinic 611 Adherence
Nam 2010 Vietnam Cross sectional HIV + adults Clinic 353 Initiation ART
Okonsy 2011 USA Cross sectional HIV + adults Clinic 558 Adherence
Peltzer 2011 South Africa Cross sectional HIV + adults Clinic 735 Adherence
Pettifor 2010 South Africa Cross sectional People over 15 years old Community 198 HIV testing
Pinheiro 2002 Brazil Cross sectional HIV + adults Clinic 195 Adherence
Remien 2007 Brazil Cross sectional HIV + adults Clinic 200 Adherence
Rintamaki 2006 USA Cross sectional HIV + adults Clinic 204 Adherence
Sambisa 2010 Zimbabwe Cross sectional People over 15 years old Community 12,254 HIV testing
Sarna 2008 India Cross sectional HIV + adults Clinic 310 Adherence
Sayles 2006 USA Longitudinal HIV + adults Clinic 1,910 Adherence
Sayles 2009 USA Cross sectional HIV + adults Clinic 202 Adherence
Van Servellen 2005 USA Cross sectional HIV + adults Clinic 85 Adherence
Wang 2007 China Cross sectional HIV + adults Clinic 181 Adherence
Watt 2009 Tanzania Cross sectional HIV + adults Clinic 340 Adherence
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barriers associated to HIV testing included belonging to the
age group from 25 to over 45 [17,22], having unprotected
sex and having sex with a non-spousal or non-cohabiting
partner [17] and anticipated stigma [17,22].
Non-uptake of ART in high income countries was only
statistically significantly associated with having other
competing subsistence needs [26]. In low income countries,
the barriers to initiate ART included indirect costs of health
care, not having a known HIV-positive family member,
non-disclosure of HIV status and having additional
pregnancies [11,19,20].
In high income countries, low adherence to ART was
associated with being black [41,44], being between 25-34
years old [27,41] and having less than primary education
[27]. Other barriers were clinical and treatment factors
such as protease inhibitor ART regimens [34], frequent
doses of ART [29,37], experience of side effects [34,38],
feeling unhappy with the treatment [25], initiating the
treatment with a CD4 count over 200 Cells/mL3 [31].
Alcohol and/or substance abuse [24,27-29,33] and an-
ticipated and internalized stigma were associated with
low levels of adherence [29,33,35,39].
Table 2 Outline of the factors identified per study
Country group Source Clinical Disclosure Location Violence Risk
behavior
Health
system
Health
Beliefs
Psychosocial Social
support
SES Stigma
Low and low
middle income
countries
Boyer x . . . x x . . x x x
Carlucci x . . . . x . . . . x
Charurat x x . . . x . . . x .
Franke x . . . x . . x x x x
Giday x . . . x . . . x x .
Karcher x . . . . . . . . . .
Koku . . . . x . x x . x x
Martinez x . . . x . . x . . .
Nam x x . . x x . . x x .
Sarna x . . . . x . x . x .
Watt . . . . . x . x . . .
Kranzer_b . . x . . . . . . x .
Sambisa . . . . x . x . . x x
High and upper
middle income
countries
Aloisis x . . . x . . . . . .
Bardford x . . . x x . x x . .
Cunningham . . . . . . . x . x .
De Castilho x . . . x . . x . . .
Gebo . . . . x . x . x x .
Grierson x . . . x x x x . . x
Holmes . . . . x . . . . x .
Kranzer x . . . . . . . . . .
Li x x . . . x . x x x x
Mugavero . . . . x . . x . x .
Okonsy x . . . . . . . x . .
Peltzer x . . . x . . x x x x
Pettifor x x . . . x x . . . x
Pinheiro x . . . . . . . . x .
Remien x . . . . . . x . . .
Rintamaki x . . . . . . . . . x
Sayles _a . . . . . . . x . . x
Sayles_b x . . x x . . x . x .
Vanservellen x . . . . x x x x . .
Wang x . . . . x . . . . .
Mc Phail x x . . x . x . . . x
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Potential relevant citations identified 
through search strategy
N=956
(excluding duplicate citations)
Articles retrieved for full text 
screening
N= 141
Articles included in the quality 
appraisal
N=55
Articles included in the review
N=34
Excluded: 21
- analysis did not deal with
confounders
Excluded: 86
- after full screen due to wrong
design (no quantitave survey),
population (children or adolescents),
wrong explanatory variables (no
socio-cultural variables other than
socio-demographic or socio-
economic), wrong outcomes (no
effectsestimates)
Excluded: 815
- after first screen of titles and
abstracts due to wrong design (no
quantitave survey), wrong study
population (children or adolescents),
or wrong outcome (noHIV-continuum
of care)
Figure 1 Flow chart.
Figure 2 Proportion of factors (%) in studies carried out in HIC vs LIC.
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In low income countries, age groups associated with
low adherence to ART were 19-30 years and over 50
years [21]. The latter deviate from the risk age reported
from high income countries where being over 50 was
found to be protective. Other risk factors included
having a main couple but not living together [11], being
Muslim [13], being female [14], food insufficiency [14]
and household financial problems [11,15]. Alcohol abuse
and experienced discrimination were associated with low
adherence also in low income countries [11]. With respect
to clinical and treatment factors in low income countries
initiation of ART with CD4 over 200 cells/ml3, being on
ART less than 15 months [13,15] and having switched
ART regimen [11] were associated with low adherence.
Health system barriers included ARV stock outs, inad-
equate communication with health staff [11,13,21] and
health care indirect costs [11,19,20]. One study reported an
inverse association between free cost of ARV and adherence
[20]. Concerning interpersonal and psychosocial factors,
perceived lack of family support [11], not having disclosed
to the family members [19] and feeling depressed [20] were
negatively associated with adherence.
Reported protective factors significantly associated with
access to HIV/AIDS services across countries
In high income countries, protective factors for uptake
of HIV testing were being female [36,44], having a history
of previous illnesses [31,34,41,44], having disclosed and/or
having conversations about HIV/AIDS with parents [44]
and believe that most people do not want to get tested for
HIV or do it only if they are sick [36,44]. In low income
countries, being educated beyond primary school [17],
single [22], affiliated to non Christian religions [17],
living in a high prevalence community [22], knowing
someone infected with HIV/AIDS [22], practicing safer
sexual behaviours such as using condoms and being
exposed to media [17,22] were positively associated with
uptake of testing.
In low income countries, belonging to the age group
30 to 40 years of age and having greater than a primary
school education facilitated initiation of ART [18]. Not
drinking alcohol in the past year was also a protective
factor [22]. No protective effects were reported from
high income countries.
In high income countries, being older than 50 years of
age [29] and on ART treatment for more than two years
were positively associated with adherence to ART [35].
Previous illnesses or having other health conditions were
positively associated with good adherence [31,34,41,44].
Self-perception of good health status [35,38] and no
consumption of alcohol in the past year [30] were also
protective. Good family communication [32,42], higher
levels of treatment information [35] and believing in
the benefits of ARVs [28] were facilitators of adherence. In
low income countries, good social support and self-efficacy
were positively associated with adherence as well as having
disclosed to at least one family member about one’s
positive HIV status [13,14]. Experiencing other health
conditions was also associated with a protective effect
on adherence [31,35,41,44].
No studies reported significant risk effects for defaulting.
Combined effect sizes associated with adherence.
The pool estimates of the 34 studies which included
socio-cultural factors are shown for a) general socio-
demographic factors, and b) specific socio-cultural factors.
Due to an insufficient number of studies for other out-
comes, only adherence could be included in the model.
The meta-analysis showed that being male was associ-
ated with optimal adherence in low income countries
(OR= 0.16, 95%CI= 0.04-0.66) while the association with
being female was not statistically significant. Conversely,
Table 3 Ranking of proportion (%) of factors studied in low and high income countries
Low income countries High income countries
Rank % Rank %
1 Socio-demographic factors 92% 1 Clinical factors 76%
2 Clinical factors 69% 2 Socio-demographic factors 52%
3 Socio-economic factors 69% 3 Psychosocial factors 52%
4 Health behavior factors 54% 4 Health behavior factors 48%
5 Health system factors 46% 5 Socio-economic factors 38%
6 Psychosocial factors 38% 6 Stigma and discrimination 33%
7 Stigma and discrimination 38% 7 Health system factors 29%
8 Social and family support 31% 8 Social and family support 29%
9 Knowledge and beliefs 15% 9 Knowledge and beliefs 24%
10 Communication and disclosure 15% 10 Communication and disclosure 14%
11 Community characteristics 8% 11 Domestic Violence 5%
12 Domestic Violence 0% 12 Community characteristics 0%
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in high income countries low adherence was associated
with females (OR= 1.29, 95%CI: 1.06-1.58) while the
association with male was not statistically significant.
Being single (OR= 2.72, 95%CI= 1.58-4.69), and younger
than 30 (OR= 1.04, 95%CI= 1.01-1.07) was significantly
associated with lower adherence in low income countries.
Being older than 50 years of age was associated with
optimal adherence (OR= 0.80, 95%CI= 0.59-1.07) and was
Table 4 Meta-estimates: effect of socio-demographic factors on adherence to ART
Socio-demographic Pool ES CI 95% p value* Pool studies I2
Male 0.77 0.48-1.24 0.28 7 61.3%
High income countries 0.94 0.57-1.55 0.81 4 54.6%
Low income countries 0.16 0.04-0.66 0.01 3 0.0%
Female 1.05 0.97-1.13 0.27 7 49.1%
High income countries 1.29 1.06-1.58 0.01 4 34.6%
Low income countries 0.99 0.91-1.08 0.85 3 0.0%
Married 1.10 0.85-1.42 0.46 2 0.0%
High income countries 1.10 0.84-1.45 0.49 1 -
Low income countries 1.10 0.56-2.16 0.78 1 -
Single 2.49 1.51-4.12 0.00 3 0.0%
High income countries 1.53 0.42-5.56 0.52 1 -
Low income countries 2.72 1.58-4.69 0.00 2 -
Separated/divorced - - - - -
High income countries - - - - -
Low income countries 1.07 0.42-2.73 0.89 2 0.0%
Age less than 20 1.14 0.96-1.37 0.14 2 60.1%
High income countries 0.47 0.96-1.37 0.13 1 -
Low income countries 1.18 0.98-1.42 0.08 1 -
Age less than 30 1.04 1.01-1.07 0.01 2 0.0%
High income countries - - - - -
Low income countries 1.04 1.01-1.07 0.01 2 0.0%
Age 20-30 1.38 1.21-1.58 0.00 5 60.2%
High income countries 1.30 0.86-1.94 0.21 3 20.2%
Low income countries 1.39 1.21-1.60 0.00 2 74.0%
Age 30-50 1.08 0.97-1.19 0.16 6 0.0%
High income countries 1.06 0.77-1.46 0.72 4 0.2%
Low income countries 1.08 0.97-1.20 0.17 2 0.0%
Age over 50 years 0.80 0.59-1.08 0.14 5 59.4%
High income countries 0.55 0.41-0.75 0.00 4 0.0%
Low income countries 6.68 3.15-14.15 0.00 1 -
No education 1.76 1.19-2.60 0.01 3 0.0%
High income countries 1.69 0.82-3.48 0.16 1 -
Low income countries 1.78 1.12-2.85 0.02 2 0.0%
Primary education 0.98 0.85-1.13 0.80 4 9.3%
High income countries 0.99 0.86-1.15 0.91 3 0.0%
Low income countries 0.30 0.06-1.49 0.14 1 -
Secondary education 1.04 0.95-1.14 0.43 10 60.4%
High income countries 1.03 0.95-1.28 0.75 6 73.7%
Low income countries 1.04 0.94-1.15 0.47 4 19.8%
Tertiary education 0.85 0.58-1.24 0.39 3 60.9%
High income countries 0.69 0.45-1.07 0.10 2 44.8%
Low income countries 1.56 0.73-3.34 0.25 1 -
*Significance level p<0.05.
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statistically significant in both settings; having no education
was significantly associated with suboptimal adherence
(OR= 1.76, 95%CI= 1.18-2.60) in both settings.
Socio-cultural factors associated with lower adherence
included perceived lack of social support although suffi-
cient data were available only in high income countries
(OR= 1.04, 95%CI: 1.01-1.07). Perceived social stigma
had an overall risk factor (OR= 2.17, 95%CI= 1.52-3.09)
in both settings. High risk health behaviours such as
alcohol abuse (OR= 1.75, 95%CI= 1.41-2.18) and abuse
drugs (OR= 1.86, 95%CI= 1.48-2.33) were also significant
in both settings, while low levels of self-efficacy were
negatively associated with adherence in both settings.
This effect was stronger in high income countries
(OR=2.13 95%CI=1.03-4.41) than in low income countries
(OR= 1.75 95%CI=1.91-1.31). Absence of symptoms of
depression was positively associated with optimal ad-
herence in both settings (OR= 0.89, 95%CI= 0.83-0.96).
Tables 4 and 5 summarize the meta estimates of the socio-
demographic and socio-cultural factors respectively.
Discussion
This review revealed a trend in quantitative survey studies
to explore the same kinds of factors in relation to access
to HIV/AIDS services. Overall the most studied factors in
all regions, including Africa, Asia, Latin America and
some groups and communities in North America, were
socio-economic, medical and health risk behaviour. In
low-income countries the research focus was on socio-
economic and health system factors while in high-income
more attention was given to clinical and psychosocial
factors such as depression, anxiety, self-efficacy and/or
sexual identity. Socio-cultural factors including social
and family support, interpersonal violence, and disclosure
about HIV/AIDS received, in comparison, very little
attention in both rich and poor countries.
These results should call the attention of survey
researchers and systematic reviewers. The aforementioned
socio-cultural factors have been widely published in quali-
tative studies [2-6] as critical factors that influence access
to HIV/AIDS services, both in high and in low income
countries. However most of the quantitative studies
included in our review, from both high and low income
countries, omitted them in their surveys or explored them
very superficially. This is not justified as these factors are
key issues for survey research. Our results suggest that the
problem lied in the exclusion of qualitative information in
the questionnaire design. Of the 34 studies included in this
review, 27 [12-18,20,22-24,27,28,30-36,38-44] used validated
measures from previous quantitative studies to derive their
questionnaires and only seven studies, three, in low income
countries [11,19,21] and four in high income countries
[25,26,29,37], conducted an informative phase, using quali-
tative methods, to inform the questionnaire development.
The exclusion of qualitative information during the
questionnaire design in the rest of the studies could have
led to over-emphasis in the research of the same kind of
easily measured variables.
This compromises the interpretation and generalization
of the evidence and its application to inform health policies
Table 5 Meta-estimates: effect of socio-cultural factors on adherence to ART
Socio-cultural Pool ES CI 95% p value* Pool studies I2
Low self-efficacy 1.025 0.57-1.85 0.94 3 63.1%
High income countries 2.13 1.03-4.41 0.01 2 0.0%
Low income countries 1.75 1.91-1.31 0.04 1 -
Lack of social support
High income countries 1.04 1.01-1.08 0.02 2 0.0%
Low income countries - - - - -
No depression 0.89 0.83-0.96 0.00 2 0.0%
High income countries 0.92 0.82-1.04 0.17 1 -
Low income countries 0.88 0.80-0.96 0.01 1 -
Stigma 2.17 1.52-3.09 0.00 2 62.1%
High income countries 3.70 1.92-7.42 0.00 1 -
Low income countries 1.74 1.14-2.65 0.01 1 -
Abuse of alcohol 1.75 1.41-2.18 0.00 6 59.8%
High income countries 1.43 1.09-1.86 0.01 4 24.0%
Low income countries 2.72 1.84-1.69 0.00 2 32.7%
Abuse of drugs 1.86 1.48-2.33 0.01 9 1.1%
High income countries 1.89 1.49-2.41 0.00 6 23.2%
Low income countries 1.58 0.78-3.22 0.21 3 0.0%
*Significance level p<0.05.
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Table 6 Overview of measurement tools used to evaluate same socio-cultural constructs in different studies
Source Year Country Outcome Measurement instrument
Family support
Boyer 2011 LIC Adherence Self-reported
Bardford 2005 HIC Non adherence Self-reported
Li 2010 HIC Adherence Adapted from FAD
Social support
Vanservellen 2005 HIC Adherence MOS scale
Li 2010 HIC Adherence Adapted from MOS Scale
Franke 2011 LIC Adherence Duke-UNC Functional Social Support Questionnaire
Peltzer 2010 HIC Adherence Adapted Social Support Questionnaire
Okonsy 2011 HIC Adherence Rates social support 1 to 10
Giday 2010 LIC Adherence Own questions
Self-efficacy
Franke 2011 LIC Adherence ACTG
Remien 2007 HIC Adherence ACTG
Vanservellen 2005 HIC Adherence ACTG
Watt 2009 LIC Adherence 10 item scale adapted
Depression
Martinez 2008 LIC Initiation ART Hopkins Symptoms Checklist
Franke 2011 LIC Adherence Hopkins Symptoms Checklist
Peltzer 2010 HIC Adherence CES-D
Vanservellen 2005 HIC Adherence CES-D
Mugavero 2006 HIC Adherence BSI
Sarna 2008 LIC Adherence BDI
Bardford 2005 HIC Non adherence ACTG
Li 2010 HIC Adherence Thai Department of Mental Health
Source Year Country Outcome Measurement instrument
Patient-provider relationship
Bardford 2005 HIC Non adherence Self-reported
Vanservellen 2005 HIC Adherence Satisfaction survey
Watt 2009 LIC Adherence 9 item scale adapted from Panpanich 2004
Quality of life
Franke 2011 LIC Adherence Medical Outcomes Study HIV Health Survey
Peltzer 2010 HIC Adherence WHOQOL-HIVBREF
Stigma
Rintamaki 2006 HIC Adherence 3 items from PMAQ
Franke 2011 LIC Adherence Berger Scale
Carlucci 2011 LIC Adherence Own scale
Pettifor 2004 HIC HIV testing Genberg scale
Li 2010 HIC Adherence Adapted from Herek and Capitanio
Sayles _a 2009 HIC Adherence Own scale
Koku 2011 LIC HIV testing 2003-GDHS
Dicrimination
Boyer 2011 LIC Adherence Self reported
Grierson 2011 HIC Adherence Self reported
Peltzer 2010 HIC Adherence Own 7 items scale
Pettifor 2004 HIC HIV testing Genberg scale
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and programs. Indeed, this review showed that according
to the quantitative evidence the factors studied to assess
the barriers to access HIV/AIDS services inexplicably differ
between richer and poorer countries contrary to the
evidence from qualitative studies.
Additionally, due to an insufficient number of consistent
studies for other outcomes, only adherence outcomes
could be meta-analysed. The meta-analysis of the other
outcomes proved untenable as the wide range of instru-
ments and indicators used to assess socio-cultural variables
such as social support, stigma, depression, and self-efficacy,
introduced too much heterogeneity in the studies and
impeded the pooling and synthesis of the results. Table 6
shows the variability of the instruments used to assess the
same indicator. Risk factors of low-adherence, in both rich
and poor countries, were stigma and discrimination, alco-
hol and drug abuse, depression and low self-efficacy. Social
support was the only factor that showed a protective effect.
Yet, it is unclear whether this effect occurred equally in rich
and poor countries as enough data were available only from
high income countries. The comparative approach between
high and low income countries of this systematic review
and meta-analysis has several advantages over pooling all
countries included in the review. This comparative nature
yielded valuable information about the differences and
similarities of social and cultural processes that affect access
to treatment in each context. The comparison also reveals
a potential bias in the factors studied in the different
regions that may be motivated by cultural stereotypes
and has also facilitated the detection of trends and the
identification of gaps in the surveys conducted which
otherwise would have remained in the shadows. Thus this
comparative approach has helped to produce a more
detailed description of these gaps which can be beneficial
for the preparation of future surveys in this field.
There are several limitations to our study. Publication
bias may be limiting our systematic review of quantitative
studies although we have used Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [45] to examine reporting and other biases in
a systematic way. See Additional file 1 for further details.
Another limitation is the difference between the timing of
the preparation of the surveys and the one of the publica-
tions of qualitative studies. We would not expect a survey
published in the early 90s to be aware of the problems
identified in qualitative studies published later. But our
analysis indicates that in general the quantitative studies
have not systematically addressed important issues identi-
fied in qualitative studies that were published at least two
years before the implementation of their surveys.
Conclusions
This review has highlighted a number of issues requiring
further research and demonstrated the need to improve
the research strategy in epidemiological survey studies.
Improvement of this strategy requires better integration
of the findings of qualitative studies in quantitative sur-
veys and more consistency between survey studies. This
review also offered evidence of the lack of consistency in
the measurement of socio-cultural factors which hinders
comparisons between studies.
We recommend that, prior to developing a questionnaire,
literature reviews should be systematically carried out
including qualitative studies. This would help to identify
appropriate themes for the context avoiding the tendency
to focus on the same topics. We further recommend using
validated instruments giving priority to cultural adapta-
tions over the development of new measures. We also call
for a generalization of some variables without limiting the
specificity of the various contexts. For example, it would
be useful to report the effects of different types of stigma,
as defined by subscales of validated tools, rather than
global scores which cannot be disentangled and are
less informative. Another example is the social support
measure which could also be broken down by subtypes,
material, emotional, etc.
Further quantitative research is needed on socio-cultural
determinants of HIV testing, initiation of antiretroviral
therapy and defaulting in both low- and high-income
countries. More consistency between qualitative and
quantitative research and between quantitative measures
of socio-cultural factors will help to increase the quality of
the data collected, to enhance comparability which is a
prerequisite for meta-analyses, to avoid duplication and in
general to produce better scientific evidence to inform
managers and policy-makers working on HIV/AIDS.
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